Provided by Tiger Trade Technology Pte. Ltd.

Evolus Inc.

7.14
-0.5500-7.15%
Post-market: 7.140.00000.00%19:30 EDT
Volume:2.07M
Turnover:14.97M
Market Cap:470.20M
PE:-13.56
High:7.72
Open:7.72
Low:6.91
Close:7.69
52wk High:9.31
52wk Low:3.86
Shares:65.85M
Float Shares:47.53M
Volume Ratio:3.65
T/O Rate:4.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5267
EPS(LYR):-0.8010
ROE:-18729.61%
ROA:-5.68%
PB:-15.22
PE(LYR):-8.91

Loading ...

Evolus Price Target Maintained With a $13.00/Share by BTIG

Dow Jones
·
Jun 17

Evolus shareholders elect Brady Stewart, Vikram Malik as Class II directors

Reuters
·
Jun 13

Evolus (EOLS) Receives a Buy from Mizuho Securities

TIPRANKS
·
Jun 09

Evolus files $250M mixed securities shelf

TIPRANKS
·
Jun 06

Evolus - May Offer up to $250 Mln of Securities - SEC Filing

THOMSON REUTERS
·
Jun 06

Evolus management joins Jefferies Global Healthcare Conference fireside chat

Reuters
·
May 19

3 High-Growth Insider-Owned Companies With Earnings Surging Up To 80%

Simply Wall St.
·
May 15

Evolus Plans to Launch Estyme Collection in Europe

MT Newswires Live
·
May 11

Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe

THOMSON REUTERS
·
May 11

Evolus Faces Heightened Operational Risk from Overseas Manufacturing and Disaster Recovery Gaps

TIPRANKS
·
May 06

BTIG Sticks to Their Buy Rating for Evolus (EOLS)

TIPRANKS
·
May 05

Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (ADCT), Evolus (EOLS) and Nuvation Bio (NUVB)

TIPRANKS
·
May 05

Evolus Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 05

Evolus publishes investor presentation outlining aesthetics growth strategy and Evolysse rollout

Reuters
·
May 05

Evolus publishes scientific investor presentation on Evolysse hyaluronic acid filler technology

Reuters
·
May 05

Evolus Q1 revenue rises 7% on product sales

Reuters
·
May 05

Evolus Q1 operating loss narrows to $6.8 million; revenue rises 7% to $73.1 million

Reuters
·
May 05

Evolus Q1 Adj. EPS $(0.16) Misses $(0.13) Estimate, Sales $73.137M Beat $72.288M Estimate

Benzinga Earnings
·
May 05

BRIEF-Evolus Q1 Product Revenue USD 72.747 Million

Reuters
·
May 05

Evolus Q1 Gross Profit USD 48.897 Million

THOMSON REUTERS
·
May 05